M3 (2413) Price & Analysis

Compare

3 Followers

2413 Stock Chart & Stats

¥2157.00

¥5.00(0.35%)

At close: Jan 08 4:00 PM EST

¥2157.00

¥5.00(0.35%)

Day’s Range― - ―

52-Week Range¥1,441.00 - ¥2,746.00

Previous CloseN/A

Volume2.86M

Average Volume (3M)2.99M

Market Cap

¥1.10T

Enterprise Value¥999.07B

Total Cash (Recent Filing)¥102.14B

Total Debt (Recent Filing)¥26.14B

Price to Earnings (P/E)22.2

Beta0.90

Next Earnings

Apr 24, 2026

EPS Estimate

15.08

Next Dividend Ex-DateN/A

Dividend Yield1.01%

Share Statistics

EPS (TTM)27.95

Shares Outstanding679,115,800

10 Day Avg. Volume2,689,370

30 Day Avg. Volume2,988,500

Financial Highlights & Ratios

PEG Ratio-2.70

Price to Book (P/B)3.05

Price to Sales (P/S)4.06

P/FCF Ratio25.43

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

¥2,710.00

Price Target Upside25.64% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering10

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Strong Free Cash FlowM3's large absolute free cash flow and strong cash conversion provide durable internal funding for product investment, acquisitions, and shareholder returns. Robust FCF cushions the business through cycles and supports multi-year strategic initiatives without relying on external financing.

Conservative Balance SheetA high equity ratio and very low leverage give M3 financial flexibility to invest in growth, absorb industry shocks, and pursue M&A opportunistically. This conservative structure lowers financial risk and preserves capital allocation optionality over the coming 2–6 months and beyond.

High Margin & Revenue GrowthDouble-digit revenue growth coupled with a >50% gross margin indicates a scalable, high-value digital platform and pricing power in healthcare services. This combination supports sustainable operating leverage and reinvestment capacity to reinforce market position over time.

Bears Say

Declining Profitability MetricsThe material drop in EBIT margin and ROE signals reduced operating efficiency or competitive/structural pressures. If persistent, this erosion can limit the firm's ability to convert revenue growth into shareholder returns and constrain long-term reinvestment and dividend capacity.

Moderated FCF Growth From Higher CapexRising capital expenditures that moderate FCF growth can be necessary for platform investment, but sustained higher capex reduces near-term cash remitability. Unless these investments drive commensurate revenue and margin gains, they may weaken cash available for buybacks or dividends.

Net Margin CompressionA declining net margin despite revenue expansion suggests cost pressure or lower pricing power in parts of the business. Structural margin compression would reduce cashflow generation per revenue unit and make it harder to restore historical ROE and fund strategic initiatives sustainably.

M3 News

M3 Builds Momentum With Double-Digit Profit Growth, Sticks to FY2026 Outlook

M3 ( ($JP:2413) ) just unveiled an announcement. The company delivered strong nine-month FY2025 results, with revenue climbing...

12d ago

MTHRF Earnings this Week: How Will it Perform?

M3 (MTHRF) is scheduled to report 3rd quarter earnings on 02/04/2026. Regarding Q3 estimates, Wall Street analysts expect...

14d ago

M3 Reports Progress on Ongoing ¥20 Billion Share Buyback Program

M3 ( ($JP:2413) ) has provided an update. M3, Inc. has reported the status of its ongoing share...

14d ago

M3 Continues Share Buyback, Uses Fraction of ¥20 Billion Authorization

The latest update is out from M3 ( ($JP:2413) ). M3, Inc. has disclosed the latest status of...

1M ago

M3 Introduces Long-Term Stock Option Incentives to Align Employee and Shareholder Interests

M3 ( ($JP:2413) ) has shared an announcement. M3, Inc. has approved the issuance of share-based remuneration stock...

2M ago

M3, Inc. Announces Share Repurchase Update

The latest update is out from M3 ( ($JP:2413) ). M3, Inc. announced the repurchase of 149,400 of...

3M ago

M3, Inc. Reports Strong First Half 2025 Growth

M3 ( ($MTHRF) ) has released its Q2 earnings. Here is a breakdown of the information M3 presented...

3M ago

M3, Inc. Updates on Share Repurchase Program

M3 ( ($JP:2413) ) has issued an update. M3, Inc. announced the status of its share repurchase program,...

3M ago

MTHRF Upcoming Earnings Report: What to Expect?

M3 (MTHRF) is scheduled to report 2nd quarter earnings on 11/12/2025. Regarding Q2 estimates, Wall Street analysts expect...

3M ago

M3 Inc. downgraded to Neutral from Buy at Goldman Sachs

Goldman Sachs downgraded M3 Inc. (MTHRF) to Neutral from Buy with a 2,500 yen price target The firm...

4M ago

M3, Inc. Updates on Share Repurchase Program

The latest announcement is out from M3 ( ($JP:2413) ). M3, Inc. announced the status of its share...

4M ago

M3 Inc. initiated with a Buy at Goldman Sachs

Goldman Sachs analyst Akinori Ueda initiated coverage of M3 Inc. with a Buy rating and 5,450 yen price...

3y ago

MTHRF

2413 FAQ

What was M3 Inc’s price range in the past 12 months?

M3 Inc lowest stock price was ¥1441.00 and its highest was ¥2746.00 in the past 12 months.

What is M3 Inc’s market cap?

M3 Inc’s market cap is ¥1.10T.

When is M3 Inc’s upcoming earnings report date?

M3 Inc’s upcoming earnings report date is Apr 24, 2026 which is in 67 days.

How were M3 Inc’s earnings last quarter?

M3 Inc released its earnings results on Feb 04, 2026. The company reported ¥27.95 earnings per share for the quarter, beating the consensus estimate of ¥21.828 by ¥6.122.

Is M3 Inc overvalued?

According to Wall Street analysts M3 Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does M3 Inc pay dividends?

M3 Inc pays a Annually dividend of ¥21 which represents an annual dividend yield of 1.01%. See more information on M3 Inc dividends here

What is M3 Inc’s EPS estimate?

M3 Inc’s EPS estimate is 15.08.

How many shares outstanding does M3 Inc have?

M3 Inc has 679,115,800 shares outstanding.

What happened to M3 Inc’s price movement after its last earnings report?

M3 Inc reported an EPS of ¥27.95 in its last earnings report, beating expectations of ¥21.828. Following the earnings report the stock price went down -2.93%.

Which hedge fund is a major shareholder of M3 Inc?

Currently, no hedge funds are holding shares in JP:2413

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

M3 Inc

M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. It operates m3.com, a members-only Web site for providing information to the healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; QOL-kun that provides life support information other than medical information to members; AskDoctors, where registered doctors answer questions about health and illness from the general public; MDLinx for medical professionals in the United States; and Doctorsnetuk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain. The company also provides career services for doctors and pharmacists through m3com CAREER. In addition, it engages in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; survey service for medical professionals; sale and marketing support businesses for pharmaceutical companies, etc. through the Internet; provision of management support and consulting services to medical institutions, and home-visit nursing services; and provision of human resources services for healthcare professionals, as well as operates clinical trial facilities. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.

M3 (2413) Earnings & Revenues

Historic Earnings Reports

2413 Stock 12 Month Forecast

Average Price Target

¥2,710.00

▲(25.64% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1401":"¥1,401","1981":"¥1,981","2561":"¥2,561","3141":"¥3,141","3721":"¥3,721"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3720,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥3.72K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2710,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥2.71K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2300,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥2.30K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1401,1981,2561,3141,3721],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1882,2023.3846153846155,2164.769230769231,2306.153846153846,2447.5384615384614,2588.923076923077,2730.3076923076924,2871.6923076923076,3013.076923076923,3154.4615384615386,3295.846153846154,3437.2307692307695,3578.6153846153848,{"y":3720,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1882,1945.6923076923076,2009.3846153846155,2073.076923076923,2136.769230769231,2200.4615384615386,2264.153846153846,2327.846153846154,2391.5384615384614,2455.2307692307695,2518.923076923077,2582.6153846153848,2646.3076923076924,{"y":2710,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1882,1914.1538461538462,1946.3076923076924,1978.4615384615386,2010.6153846153845,2042.7692307692307,2074.923076923077,2107.076923076923,2139.230769230769,2171.3846153846152,2203.5384615384614,2235.6923076923076,2267.846153846154,{"y":2300,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1473.107,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1402.96,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1688.5,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1783,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2023.5,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1926,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1890,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2254,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2267.5,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2169.5,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2453.5,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2114,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1882,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >